Overview
Albert Feghaly practices in Montreal, Canada. Mr. Feghaly is rated as an Experienced expert by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. His top areas of expertise are Cerebral Hypoxia, WT1-Related Wilms Tumor Syndromes, Acute Myeloid Leukemia (AML), and Leukemia.
His clinical research consists of co-authoring 12 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 1 article in the study of WT1-Related Wilms Tumor Syndromes.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Acute Myeloid Leukemia (AML)Mr. Feghaly isExperienced. Learn about Acute Myeloid Leukemia (AML).
- Cerebral HypoxiaMr. Feghaly isExperienced. Learn about Cerebral Hypoxia.
- LeukemiaMr. Feghaly isExperienced. Learn about Leukemia.
- WT1-Related Wilms Tumor SyndromesMr. Feghaly isExperienced. Learn about WT1-Related Wilms Tumor Syndromes.